190 related articles for article (PubMed ID: 8255100)
21. Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease.
Szczepański T; Langerak AW; Wolvers-Tettero IL; Ossenkoppele GJ; Verhoef G; Stul M; Petersen EJ; de Bruijn MA; van't Veer MB; van Dongen JJ
Leukemia; 1998 Jul; 12(7):1081-8. PubMed ID: 9665194
[TBL] [Abstract][Full Text] [Related]
22. Detection of immunoglobulin kappa light-chain gene rearrangement patterns by Southern blot analysis.
Beishuizen A; Verhoeven MA; Mol EJ; van Dongen JJ
Leukemia; 1994 Dec; 8(12):2228-36; discussion 2237-9. PubMed ID: 7808012
[TBL] [Abstract][Full Text] [Related]
23. Detection of minimal residual disease: methods and relationship to outcome in T-lineage acute lymphoblastic leukemia.
Dibenedetto SP; Lo Nigro L; Di Cataldo A; Schilirò G
Leuk Lymphoma; 1998 Dec; 32(1-2):65-75. PubMed ID: 10037002
[TBL] [Abstract][Full Text] [Related]
24. T-cell-directed TAL-1 expression induces T-cell malignancies in transgenic mice.
Condorelli GL; Facchiano F; Valtieri M; Proietti E; Vitelli L; Lulli V; Huebner K; Peschle C; Croce CM
Cancer Res; 1996 Nov; 56(22):5113-9. PubMed ID: 8912842
[TBL] [Abstract][Full Text] [Related]
25. IgH/TCR delta PCR oligonucleotide liquid hybridization, a fast and sensitive assay for monitoring minimal residual disease in childhood B-precursor ALL.
Steenbergen EJ; Verhagen OJ; van Leeuwen EF; van den Berg H; Behrendt H; von dem Borne AE; van der Schoot CE
Leukemia; 1995 Jan; 9(1):216-22. PubMed ID: 7845021
[TBL] [Abstract][Full Text] [Related]
26. Use of oligonucleotide probes directed against T cell antigen receptor gamma delta variable-(diversity)-joining junctional sequences as a general method for detecting minimal residual disease in acute lymphoblastic leukemias.
Macintyre EA; d'Auriol L; Duparc N; Leverger G; Galibert F; Sigaux F
J Clin Invest; 1990 Dec; 86(6):2125-35. PubMed ID: 2174915
[TBL] [Abstract][Full Text] [Related]
27. Detection of T-cell receptor delta gene rearrangement in T-cell malignancies by clonal specific polymerase chain reaction and its application to detect minimal residual disease.
Chan DW; Liang R; Kwong YL; Chan V
Am J Hematol; 1996 Jul; 52(3):171-7. PubMed ID: 8756082
[TBL] [Abstract][Full Text] [Related]
28. Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology.
Nakao M; Janssen JW; Flohr T; Bartram CR
Cancer Res; 2000 Jun; 60(12):3281-9. PubMed ID: 10866322
[TBL] [Abstract][Full Text] [Related]
29. A third tal-1 promoter is specifically used in human T cell leukemias.
Bernard O; Azogui O; Lecointe N; Mugneret F; Berger R; Larsen CJ; Mathieu-Mahul D
J Exp Med; 1992 Oct; 176(4):919-25. PubMed ID: 1402666
[TBL] [Abstract][Full Text] [Related]
30. Effects of anti-tal-1 oligodeoxynucleotides in T-ALL cell lines.
Anderegg B; Horstmann M; Kabisch H
Cancer Gene Ther; 1997; 4(2):84-90. PubMed ID: 9080116
[TBL] [Abstract][Full Text] [Related]
31. Rearranged T-cell receptor beta genes represent powerful targets for quantification of minimal residual disease in childhood and adult T-cell acute lymphoblastic leukemia.
Brüggemann M; van der Velden VH; Raff T; Droese J; Ritgen M; Pott C; Wijkhuijs AJ; Gökbuget N; Hoelzer D; van Wering ER; van Dongen JJ; Kneba M
Leukemia; 2004 Apr; 18(4):709-19. PubMed ID: 14961040
[TBL] [Abstract][Full Text] [Related]
32. c-tal, a helix-loop-helix protein, is juxtaposed to the T-cell receptor-beta chain gene by a reciprocal chromosomal translocation: t(1;7)(p32;q35).
Fitzgerald TJ; Neale GA; Raimondi SC; Goorha RM
Blood; 1991 Nov; 78(10):2686-95. PubMed ID: 1824262
[TBL] [Abstract][Full Text] [Related]
33. Simultaneous SIL-TAL1 RT-PCR detection of all tal(d) deletions and identification of novel tal(d) variants.
Delabesse E; Bernard M; Landman-Parker J; Davi F; Leboeuf D; Varet B; Valensi F; Macintyre EA
Br J Haematol; 1997 Dec; 99(4):901-7. PubMed ID: 9432040
[TBL] [Abstract][Full Text] [Related]
34. SCL/Tal-1 expression in T-acute lymphoblastic leukemia: an immunohistochemical and genotypic study.
Chetty R; Pulford K; Jones M; Mathieu-Mahul D; Close P; Hussein S; Pallesen G; Ralfkiaer E; Stein H; Gatter K
Hum Pathol; 1995 Sep; 26(9):994-8. PubMed ID: 7672800
[TBL] [Abstract][Full Text] [Related]
35. Quantification of minimal residual disease in T-lineage acute lymphoblastic leukemia with the TAL-1 deletion using a standardized real-time PCR assay.
Chen X; Pan Q; Stow P; Behm FG; Goorha R; Pui CH; Neale GA
Leukemia; 2001 Jan; 15(1):166-70. PubMed ID: 11243385
[TBL] [Abstract][Full Text] [Related]
36. Clinical significance of TAL1 gene alteration in childhood T-cell acute lymphoblastic leukemia and lymphoma.
Kikuchi A; Hayashi Y; Kobayashi S; Hanada R; Moriwaki K; Yamamoto K; Fujimoto J; Kaneko Y; Yamamori S
Leukemia; 1993 Jul; 7(7):933-8. PubMed ID: 8321044
[TBL] [Abstract][Full Text] [Related]
37. T cell receptor gamma gene rearrangements as targets for detection of minimal residual disease in acute lymphoblastic leukemia by real-time quantitative PCR analysis.
van der Velden VH; Wijkhuijs JM; Jacobs DC; van Wering ER; van Dongen JJ
Leukemia; 2002 Jul; 16(7):1372-80. PubMed ID: 12094263
[TBL] [Abstract][Full Text] [Related]
38. T-cell acute lymphoblastic leukemia--the associated gene SCL/tal codes for a 42-Kd nuclear phosphoprotein.
Goldfarb AN; Goueli S; Mickelson D; Greenberg JM
Blood; 1992 Dec; 80(11):2858-66. PubMed ID: 1450410
[TBL] [Abstract][Full Text] [Related]
39. Molecular detection and characterization of clonal cell populations in acute lymphocytic leukemia by analysis of conformational polymorphisms of cRNA molecules of rearranged T-cell-receptor-gamma and immunoglobulin heavy-chain genes.
Koch OM; Volkenandt M; Göker E; Buer J; Probst M; Banerjee D; Danenberg PV; Bertino JR
Leukemia; 1994 Jun; 8(6):946-52. PubMed ID: 8207989
[TBL] [Abstract][Full Text] [Related]
40. Age-related patterns of immunoglobulin and T-cell receptor gene rearrangements in precursor-B-ALL: implications for detection of minimal residual disease.
van der Velden VH; Szczepanski T; Wijkhuijs JM; Hart PG; Hoogeveen PG; Hop WC; van Wering ER; van Dongen JJ
Leukemia; 2003 Sep; 17(9):1834-44. PubMed ID: 12970784
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
